Silverback Therapeutics, Inc.
Methods and Compositions for the Treatment of Disease with Immune Stimulatory Conjugates
Last updated:
Abstract:
Methods and conjugates are disclosed for alleviating toxicity(ies) associated with administration of immune-stimulatory conjugates, and in particular for alleviating toxicity(ies) associated with intravenous administration of such conjugates.
Status:
Application
Type:
Utility
Filling date:
11 Sep 2019
Issue date:
16 Apr 2020